Across TCGA pan-cancer cohorts, FAM197Y7 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated FAM197Y7 data layer.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher FAM197Y7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM197Y7 expression acts as an unfavorable survival marker.
LIHC, READ, and GBM are the cancer types where FAM197Y7 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.